Published by the National Foundation for Infectious Diseases | Vol. 37, No. 1 | April 2012

NFID Present Three Prestigious Awards at Annual Gala

(AWARDS, continued on page 4)

TH

EDouble Helix

IN THIS ISSUE

NFID Awards Dinner Recap ..........1

Fifteenth Annual Conference on Vaccine Research ....................2

2013 Awards Dinner Call for Nominations ................................3

Hold the Date Text Box Clinical Vaccinology Course Fall 2012 in Miami and Spring 2013 in Chicago ..............3

Flu Etiquette ...................................3

NFID Launches New Website ........6

Calendar of Events .........................6

The National Foundation for Infec-tious Diseases (NFID) honored Dr. Susan J. Rehm, Dr. George L. Drusano, and Dr. Helene D. Gayle at its annual Awards Dinner on March 27, 2012. The prestigious black-tie event was held at the Ritz-Carlton Pentagon City Hotel in Arlington, Virginia.

Dr. Drusano received the Maxwell Finland Award for Scientific Achievement, which is presented to a scientist who has made outstanding contributions to the un-derstanding of infectious diseases or public health. Dr. Gayle was honored with the Jimmy and Rosalynn Carter Humanitarian Award, which is awarded to individuals whose outstanding humanitarian efforts have contributed significantly to improving the health of people throughout the world. NFID Medical Director Dr. Susan Rehm received the John P. Utz Leadership Award, which is presented to individuals who have provided exemplary service, leadership, and vision on behalf of NFID.

The Maxwell Finland Award for Scientific Achievement

The Maxwell Finland Award is named in memory of the late Dr. Maxwell Finland, a distinguished scholar, scientist and teacher. A former member of the NFID Board of Directors, Dr. Finland was a driving force in shaping infectious diseases training pro-grams in the United States and in defining the discipline of infectious diseases as we know it today. Dr. Finland was a pioneer in the diagnosis, treatment, and epidemiol-ogy of bacterial infections, the evaluation of antimicrobials, and the demonstration of the evolving problem of antimicrobial resistance.

The 2012 Finland Award recipient, George L. Drusano, MD, is a distin-guished scholar and scientist who “helped redefine infectious disease chemotherapy as we know it today. Few scientists have made as many significant contributions

to the understanding of infectious disease chemotherapy as Dr. Drusano,” stated Paul G. Ambrose, PharmD, president of the Institute of Pharmacodynamics.

“Dr. Drusano has the ability to see indi-viduals exposed to microbials as more than just single patients, or a cohort of patients in aggregate. He is able to analyze them in terms of statistical populations with respect to the ways in which pathogens ‘see’ antimicrobials at the site of infection, and how they respond to such exposure,” added John S. Bradley, MD, director of the Division of Infectious Diseases at Rady Children’s Hospital and Associate Clini-cal Professor of Pediatrics at University of California, San Diego.

Dr. Drusano received a bachelor of science degree in physics from Boston Col-lege in 1971 and an MD degree from the University of Maryland in 1975. In 1979, he became chief resident at the University of Maryland Hospital and in the summer

of 1992 a Professor of Medicine, division of Infectious Diseases, University of Mary-land School of Medicine. He then took a position as professor at the Albany Medical

NFID Vice President Dr. Patrick Joseph (left) presents the 2012 Maxwell Finland Award for Scientific Achieve-ment to Dr. George L. Drusano. Also pictured are Dr. Paul Ambrose (second from left) and NFID President Dr. William Schaffner (right).

2 Vol. 37, No.1 | April 2012 TH

EDouble Helix

The National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt

501(c)(3) public foundation established in 1973 to educate the public and health care profession-als about the causes, treatment, and prevention

of infectious diseases.

BOARD OF DIRECTORSPresident ....................................William Schaffner, MDPresident-Elect ......................... Thomas M. File, Jr., MDVice President ...................................Patrick Joseph, MDTreasurer .................................... Larry K. Pickering, MDSecretary ....................................Walter A. Orenstein, MD

Joseph A. Bocchini, Jr., MDRichard J. Duma, MD, PhD, Director Emeritus

Kathryn M. Edwards, MDGeorge M. Eliopoulos, MD

George C. Hill, PhDKing K. Holmes, MD, PhD

Marguerite M. Jackson, PhD, RNKathryn B. Kirkland, MDDonna Mazyck, RN, MS

Peter L. Nara, DVM, PhDRonald Lee Nichols, MD

Gary A. Noskin, MDGeorges Peter, MD

Daniel J. Sexton, MDThomas G. Slama, MD

Patricia Stinchfield, RN, MS, CPNPVincent H. Tam, PharmD

Patricia Whitley-Williams, MDCynthia G. Whitney, MD, MPH

BOARD OF TRUSTEESCarol J. Baker, MD

John G. Bartlett, MDEmilio A. Emini, PhDJeffrey P. Engel, MDCraig R. Engesser

Mark B. Feinberg, MDJohn H. Johnson

Tobi Beth Karchmer, MDSamuel L. Katz, MD, DSc

William J. Ledger, MDEdward B. Lewin, MDG. Lynn Marks, MD

William J. Martone, MDSherri Michelstein, JD

Kay MitzelGeorge A. Pankey, MD

Kevin M. RooneyVijay B. Samant

Eric Schultz Leon G. Smith, MD

Edmund C. Tramont, MDC. Douglas Webb, Jr., PhD, Chairman

EXECUTIVE DIRECTORLeonard Novick

MEDICAL DIRECTORSusan J. Rehm, MD

EDITORSLeonard Novick

Susan J. Rehm, MD

ASSOCIATE EDITORSharon Cooper-Kerr

Published by National Foundation for Infectious Diseases

4733 Bethesda Avenue | Suite 750 Bethesda, Maryland 20814–5228

Telephone: 301.656.0003 | Fax: 301.907.0878 E-mail: info@nfid.org Web Site: www.nfid.org

ISSN: 1064-1815

TH

EDouble Helix NFID Announces 15th Annual Conference on Vaccine Research

The National Foundation for Infectious Diseases (NFID) will sponsor the Fifteenth Annual Conference on Vaccine Research on May 7–9, 2012, at the Hyatt Regency Inner Harbor Hotel in Baltimore, Mary-land. Collaborating organizations include the American Pharmacists Association; American Veterinary Medical Association; Center for Vaccine Development-Univer-sity of Maryland School of Medicine; Cen-ters for Disease Control and Prevention; the Edward Jenner Society; the Emory Vaccine Center; FDA Center for Biolog-ics Evaluation and Research; Fondation Mérieux; International Alliance for Bio-logical Standardization; National Institute of Allergy and Infectious Diseases/NIH; One Health Initiative; Sabin Vaccine Institute; Sealy Center for Vaccine Devel-opment, University of Texas; Society of Infectious Diseases Pharmacists; and US Department of Agriculture, Agricultural Research Service.

The conference is designed to bring together the diverse disciplines involved in the research and development of vaccines. Expert faculty from various disciplines will present the latest vaccine-related scientific data, results, and issues via symposia and panel discussions. The conference plenary sessions will focus on the following topics:

Clinical Developments in Vaccines/Vaccine Discovery; Rotavirus Vaccines; Vaccines for Enteric Diseases; Food Safety Vaccines; Vaccine Adjuvants; and Scien-tific Assessment to Recent Adverse Events Discovery.

A writing workshop, Creating Outstanding Scientific Communications: Talks, Abstracts, and Posters, will precede the conference on Sunday, May 6, 2012. This program is designed to assist scientists in preparation of sound scientific presentations while ad-dressing issues such as conflict of interest, authorship, copyright, and submission to an appropriate journal.

The NFID research conference keynote lecture, Vaccine Discovery, will be delivered by Stanley A. Plotkin, MD, Emeritus Professor of Pediatrics, University of Pennsylvania. Dr. Plotkin is currently with Vaxconsult. F. Marc LaForce, MD, PATH, will present the Mary Lou Clements-Mann Memorial Lecture, Vaccine Sciences New

Group A Meningococcal Conjugate Vaccine: Introduction in Africa.

The 15th Annual Conference on Vaccine Research will feature the presentation of the 2012 Charles Mérieux Award to Arnold Monto, MD, the Thomas Francis, Jr. Collegiate professor of Public Health at the University of Michigan School of Public Health. The award is presented to an individual who demonstrates a com-mitment to science-based medicine and research in infectious diseases, shows excel-lence in clinical and research activities and has an unsurpassed dedication to improv-ing public health.

The Robert Austrian Memorial Lecture will be delivered by NFID’s President- Elect, Thomas M. File, Jr. MD. Dr. File is professor of internal medicine and master teacher at the Northeastern Ohio Universi-ty College of Medicine and director of HIV research at Summa Health System. The lecture is named in honor of the late Rob-ert Austrian, MD, former chair of medical research at the University of Pennsylvania, who developed the first multivalent vaccine against pneumococcus bacteria.

The conference will also include Meet the Experts breakfast sessions and the pre-sentation of the Sabin Vaccine Institute’s Gold Medal.

The International Alliance for Biologi-cal Standardization (IABS) will hold its program, Potential Use of Biomarkers of In-flammation and of Early Immunological Events to Assess Vaccine Safety on May 10–11, 2012.

The conference was developed for researchers, scientists, epidemiologists, microbiologists, immunologists, molecular biologists, physicians and veterinarians, vaccine manufacturers, and public health officials who have an interest in vaccine research. NFID designates this CME activ-ity for a maximum of 19.25 AMA PRA Category 1 CreditsTM.

Continuing Education credits will be offered for nurses. The National Founda-tion for Infectious Diseases is an approved provider of continuing nursing education by the Maryland Nurses Association, an ac-credited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity has

(VACCINE RESEARCH, continued on page 5)

3 Vol. 37, No.1 | April 2012 TH

EDouble Helix

The National Foundation for Infectious Diseases (NFID) recently partnered with the Emily Post Institute to educate the public about the importance of spreading manners, not influenza through its “Are You That Guy” campaign. “That Guy” is the person who despite having flu-like symptoms con-tinues to go about his or her daily routine, often spreading the disease to others.

A recent survey of more than 1,000 Americans found that 64% of those who had influenza in the past three years admit-ted to being “that guy.” The survey found that while the majority (81%) of the people surveyed agrees that a person with the flu should cancel social obligations when she or he is sick, many admit that they don’t follow this practice.

The campaign reminds Americans to see a doctor quickly if flu strikes and offers flu etiquette tips for managing everyday situa-tions where the flu virus might be shared from one person to another such as shaking hands during a business meeting, during a family dinner or during airplane travel.

“Most of us try our best to be considerate and do the right thing,” said Anna Post, great-great-granddaughter of Emily Post and co-author of the 18th edition of the Emily Post’s Etiquette book. “While people recognize that the flu virus spreads easily, they admit to tossing proper etiquette aside when they have the flu.”

The survey found nearly four out of 10 Americans (37%) are uncomfortable telling “That Guy” that he/she is sick and should stay away from others. The Emily Post Institute recommends the following flu etiquette tips to handle common situations with social grace:

• In the workplace: If you have flu symptoms at work, let your boss know right away that you need to get to the doctor. Just let him or her know, “I don’t feel well—I need to see a doctor. I think I might have the flu.” Better to have others pitch in while you’re gone than risk others on your team becoming sick.

• In social situations: Normally it would be rude to cancel on a dinner party or big event at the last minute, but if you’re sick, call with your re-grets and instead, go see your doctor.

• Air travel: It’s tough to point out someone’s behavior mid-flight with hours left to go. However, flu is highly contagious. If there’s no other seat available, consider saying, “I can see you’re not feeling well—would you mind covering your mouth when you cough? Thanks.” Most people when prompted are eager to show good manners and do the right thing.

For additional information visit the NFID website at www.nfid.org.

NFID Issues Call for Nominations for 2013 AwardsThe National Foundation for Infectious

Diseases (NFID) is accepting nominations for

the 2013 Maxwell Finland Award for Scientific

Achievement and the Jimmy and Rosalynn Carter

Humanitarian Award.

Any individual or group may submit a nomina-

tion for The Maxwell Finland Award for Scientific

Achievement or for the Jimmy and Rosalynn Carter

Humanitarian Award. All nominations must in-

clude: (1) a nominating letter with a detailed descrip-

tion of the nominee’s accomplishments meriting

the award, not exceeding two pages in length; (2) a

seconding letter, not exceeding one page in length;

(3) a one-sentence citation summarizing the nomi-

nee’s unique contributions; and (4) the nominee’s

curriculum vitae or, in the case of nominees for the

Jimmy and Rosalynn Carter Humanitarian Award,

a biographical sketch. Only written material will

be considered. Additional information, including

nomination criteria, can be found at NFID’s website,

www.nfid.org. Nominations must be postmarked by

April 30,, 2012, and should be submitted to:

NFID Awards Committee

4733 Bethesda Avenue,

Suite 750

Bethesda, MD 20814-5278

The Awards will be presented at a black-tie dinner

in February or March, 2013 in Washington, DC.

HOLD THE DATES

Upcoming Clinical Vaccinology Courses

November 2–4, 2012

Hyatt Regency Miami

Miami, FL

March 8 – 10, 2013

Hyatt Regency Chicago

Chicago, IL

Additional details available at www.nfid.org in the late spring

NFID’s “Are You That Guy” Education Campaign Focuses on Flu Etiquette

Any individual or group may submit a nomination for The Maxwell Finland Award for Scientific Achievement or for The Jimmy and Rosalynn Carter Humanitarian

Award. All nominations must include: (1) a nominating let-ter with a detailed description of the nominee’s accomplish-ments meriting the award, not exceeding two pages in length; (2) a seconding letter, not exceeding one page in length; (3) a one-sentence citation explaining how the nominee’s overall accomplishments or specific achievements have made a national or international contribution to the area of human health; and (4) the nominee’s curriculum vitae or, in the case of nominees for The Jimmy and Rosalynn Carter Humanitarian Award, a biographical sketch. Only written material will be considered. Current members of the National Foundation of Infectious Diseases (NFID) Board of Directors or Board of Trustees are ineligible for award nomination, but may be nominated following comple-tion of board service. Persons nominated must be living at the time of nomination. Nomi-nations must be postmarked by April 23, 2012, and should be submitted to:

The Awards CommitteeNational Foundation for Infectious Diseases

4733 Bethesda Avenue, Suite 750Bethesda, MD 20814-5278

The Awards Committee of the National Foundation for Infectious Diseases will receive, consider, and make recommendations on nominations for the awards. The Committee’s recommendations for The Maxwell Finland Award for Scientific Achievement will be acted upon by the Foundation’s Board of Directors. The Committee’s recommenda-tions for The Jimmy and Rosalynn Carter Humanitarian Award will be acted upon by the Foundation’s Board of Directors and Board of Trustees.

Awards will be presented at a black-tie dinner in February or March 2013 in Washington, D.C. Recipients must be present at the ceremony to receive the awards.

Founded in 1973, the National Foundation for Infectious Diseases is as a nonprofit organization dedicated to public and professional education programs about the causes, treatment, cures, and prevention of infectious diseases.

The Maxwell Finland Award

for Scientific Achievement

and

The Jimmy and Rosalynn Carter

Humanitarian Award

National Foundation for Infectious Diseases 4733 Bethesda Avenue, Suite 750

Bethesda, Maryland 20814

Telephone: (301) 656-0003Facsimile: (301) 907-0878

E-mail: info@nfid.orgWebsite: www.nfid.org

2013

The National Foundation for Infectious Diseases

is accepting nominations for The Maxwell Finland Award

for Scientific Achievement andThe Jimmy and Rosalynn Carter

Humanitarian Award

CA

LL

FO

R N

OM

INA

TIO

NS

PR

OC

ED

UR

ES

FO

R N

OM

INA

TIN

G

NFID 2013 Awards.indd 1 1/31/2012 3:51:11 PM

4 Vol. 37, No.1 | April 2012 TH

EDouble Helix

(AWARD RECIPIENTS, from page 1)

Center Hospital. Dr. Drusano is the direc-tor of clinical pharmacology and associate director of the clinical research institute at Albany Medical College. He is a fellow of both the Infectious Diseases Society of America and the American Academy of Microbiology. He also serves as a reviewer for several scientific journals, including the Journal of the American Medical Associa-tion, the New England Journal of Medicine and the Annals of Internal Medicine. Dr. Drusano has received numerous awards, including the Rhone-Poulenc Award for innovative research with fluoroquinolones, and the American Society of Health System Pharmacy Research and Education Founda-tion Drug Therapy Award for outstanding contributions to the scientific pharmaceuti-cal literature.

The Jimmy and Rosalynn Carter Humanitarian Award

The Carter Humanitarian Award is named for President Jimmy Carter and Mrs. Carter, who as outstanding humani-tarians have worked tirelessly to improve the quality of life for people worldwide. They are co-founders of The Carter Center, a nonprofit, nonpartisan organization based in Atlanta and dedicated to im-proving the quality of life. Through The Carter Center, President and Mrs. Carter have worked to resolve conflict peacefully, promote democracy, protect human rights, prevent illness and eradicate disease.

Physician, researcher, executive and global caregiver, Helene D. Gayle, MD, MPH is the 2012 recipient of the Jimmy and Rosalynn Carter Humanitarian Award. “Helene Gayle is perhaps the most trusted global public health leader,” stated David Satcher, MD, PhD 16th Surgeon General of the United States, Director of the Satcher Health Lead-ership Institute at the Morehouse School of Medicine, and recipient of the 1999 NFID Jimmy and Rosalynn Carter Humanitarian Award. “She has a unique ability to under-stand and identify with diverse cultures throughout the world and to join them in moving to improve the health of communi-ties.”

Dr. Gayle graduated from Barnard Col-lege in 1976 with a degree in psychology. After a residency in pediatric medicine at the Children’s Hospital National Medi-cal Center in Washington, DC, Dr. Gayle served in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention (CDC). Dr. Gayle later com-pleted a residency in preventive medicine, before joining the CDC staff as epidemiolo-gist. Dr. Gayle focused on the problems of malnourished children in the United States and around the world and she implemented child survival programs in Africa. She also conducted research and worked on pro-grams and policy in the field of HIV/AIDS.

In 1992, Dr. Gayle became AIDS coordina-tor and chief of the HIV/AIDS division for

Past RecipientsMaxwell Finland Award

C. Everett Koop, MD, ScD.

Anthony S. Fauci, MD

P. Roy Vagelos, MD

Mrs. Albert Lasker

Michael E. DeBakey, MD

Arthur Ashe, Jr.

Elizabeth Hanford Dole

Honorable Dale Bumpers and Mrs. Betty F. Bumpers

Honorable Paul G. Rogers

Joshua Lederberg, PhD

Maurice R. Hilleman, PhD

Stanley Falkow, PhD

R. Gordon Douglas, MD

Robert Austrian, MD

Jerome O. Klein, MD

George W. Comstock, MD, DrPH

Robert C. Moellering, Jr., MD

George H. McCracken, Jr., MD

John G. Bartlett, MD

Herbert L. DuPont, MD

Martin S. Hirsch, MD

Stanley A. Plotkin, MD

Richard P. Wenzel, MD

R. Palmer Beasley, MD

Jimmy and Rosalynn Carter Humanitarian Award

President Jimmy Carter and Mrs. Carter

Colin L. Powell

David Satcher, MD, PhD

R. E. “Ted” Turner

Senator John D. Rockefeller, IV

William “Bill” H. Gates, III and Melinda F. Gates

John Edward Porter

Henri Landwirth

President William Jefferson Clinton

Paul E. Farmer, MD, PhD

William Foege, MD

Louis W. Sullivan, MD

Ann Lurie

Jennifer L. Howse, PhD

Tedros Adhanom Gheybreyesus, PhD

Dr. Helene Gayle receives the 2012 Jimmy and Rosalynn Carter Humanitarian Award. Pictured with NFID Presi-dent Dr. William Schaffner, Dr. David Satcher and NFID Chairman Dr. C. Douglas Webb, Jr.

(AWARD RECIPIENTS, continued on page 5)

5 Vol. 37, No.1 | April 2012 TH

EDouble Helix

the U.S Agency for International Develop-ment. In 1995, she was named Director for the National Center for HIV, STD and TB Prevention at CDC. She became the director of CDC’s Washington office and a health consultant to various international agencies including the World Health Organization, UNICEF, the World Bank and UNAIDS.

In 2001, she was appointed director of the HIV, TB, and reproductive health program which is responsible for research, programs and policies concerning HIV/AIDS, sexually transmitted diseases, repro-ductive health issues, and tuberculosis for the Bill and Melinda Gates Foundation. In 2006 Dr. Gayle became the president and CEO of Care, Inc.

In addition to overseeing the vast operations of CARE, Dr. Gayle chairs the Obama Administration’s Presidential Advisory Council on HIV/AIDS and is a member of the President’s Commis-sion on White House Fellowships. She has appeared on the list of Foreign Policy magazine’s “Top 100 Global Thinkers,” Newsweek magazine’s top 10 “Women in Leadership” and the Wall Street Jour-nal’s list of “50 Women to Watch.” She was also named as one of the “100 Most Influential Georgians” and the “100 Most Influential Atlantans.”

John P. Utz Leadership AwardSusan J. Rehm, MD received the 2012

John P. Utz Leadership Award, which is presented to individuals that have worked tirelessly in a leadership capacity on behalf of NFID. Dr. Utz was a champion in the fight against infectious diseases, and a founder of NFID. Dr. Rehm served on the NFID’s Board of Directors in 1986 to 2004, and was NFID’s President from 2001 – 2004. Since 2004 Dr. Rehm has often been the “face” of NFID while serv-ing as medical director, often appearing as spokesperson for the organization on vari-ous infectious disease topics. Dr. Rehm is vice chair of the Department of Infectious Diseases and executive director of Physician Health at the Cleveland Clinic.

Previous recipients of the John P. Utz Award include Dr. Donald M. Poretz in 2007, Dr. Carol J. Baker in 2009, Len Novick in 2010 and Dr. George C. Hill in 2011.

Honorary Co-Chairs Host Gala Event

The honorary chairs for the dinner were former President Jimmy Carter and Mrs. Carter and former President William Jefferson Clinton. C. Douglas Webb, Jr., PhD, Chairman of the NFID Board of Trust-ees and Patrick Joseph, MD, NFID Vice President, served as co-chairs for the gala.

NFID President, Dr. William Schaffner presents the 2012 John P. Utz Leadership Award to NFID Medical Director, Dr. Susan J. Rehm.

(AWARD RECIPIENTS, from page 4)

6 Vol. 37, No.1 | April 2012 TH

EDouble Helix

Calendar of NFID Events and Meetings

For more information about NFID sponsored events and meetings, please contact: Sharon Cooper-Kerr, NFID | 4733 Bethesda Avenue | Suite 750 | Bethesda, Maryland 20814-5278

Telephone: 301.656.0003, Ext 14 | Fax: 301.907.0878 | E-mail: scooper-kerr@nfid.org, or visit our website at www.nfid.org

May 7–9, 2012Fifteenth Annual Conference

on Vaccine Research

Sponsored by the National Foundation for

Infectious Diseases

Hyatt Regency Inner Harbor Hotel in Baltimore, Maryland

November 2–4, 2012Clinical Vaccinology Course

Sponsored by the National Foundation for

Infectious Diseases

Hyatt Regency Miami in Miami, Florida

March 8–10, 2013Clinical Vaccinology Course

Sponsored by the National Foundation for

Infectious Diseases

Hyatt Regency Chicago in Chicago, Illinois

April 22–24, 2013Sixteenth Annual Conference

on Vaccine Research

Sponsored by the National Foundation for

Infectious Diseases

Hyatt Regency Inner Harbor Hotel in Baltimore, Maryland

NFID Launches Redesigned Website

• Overhauled Navigation and Im-proved Search Function: It’s never been easier to find the content you’re looking for. Sometimes the easiest way to find what you’re look-ing for is simply to search the site for it. The new search engine produces more accurate results as well as an advanced search function that allows you to filter results.

• Infectious Disease Informa-tion: Provides comprehensive in-formation for consumers, patients, healthcare professionals, policy-makers, and the media on various infectious disease related topics, such as influenza and pneumococ-cal disease.

• News Stories: Key news stories are featured prominently on the homep-age along with rotating graphics to inform you of important announce-ments and upcoming events.

• Donate/Join/Subscribe: You can now subscribe to NFID email up-dates, donate to NFID, and become a supporting member directly from the homepage.

• Social Media Sharing Tools: The new and improved website allows us-ers to share content through various social media outlets and provides the ability to print or email any page on the site.

• Mobile-Friendly: A mobile-friend-ly version of the NFID website is now available. View upcoming courses and conferences, publi-cations, and news and alerts on your smart phone.

Be sure to visit www.nfid.org and send us your comments and /or suggestions.

The National Foundation for Infectious Diseases (NFID) is pleased to announce the launch of its newly redesigned website at www.nfid.org. The updated website offers visi-tors a more user-friendly resource with greatly improved design and navigation, making it faster and easier to find the essential information users have come to want and expect from NFID. Many of the changes to the website reflect suggestions NFID received from its website users and is part of our ongoing effort to provide valuable resources to all of our stakeholders.

Key updates include:

been approved for a maximum of 19.25 contact hours.

Registration fees are $620, which in-cludes a tax deductible NFID Supporting Membership. NFID will offer discounted conference admission to medical students, doctoral students, residents, fellows, physi-cian assistants, nurses, and NFID supporting members. For more information about regis-tration or abstract submission, call NFID at 301.656.0003 x19, fax: 301.907.0878, e-mail: vaccine@nfid.org or you may visit the NFID website at www.nfid.org.

(VACCINE RESEARCH, from page 2)